CONTINUITY: Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday

• Sponsor: Meir Medical Center (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT01854086
• Collaborator: (none)
• Enrollment: 150
• Location: 1

Study Details

Study Description

Brief Summary

The purpose of the study is to provide information about the rate of response and persistence to drug therapies for osteoporosis. Another issue examined in this study refers to the preferences and concerns about future treatments in patients during "drug holiday".

Condition or Disease	Intervention/Treatment	Phase
Osteoporosis	Other: Questionnaires about compliance and persistence with bisphosphonates treatment

Study Design

• Study Type: Observational [Patient Registry]
• Anticipated Enrollment: 150 participants
• Observational Model: Case-Only
• Time Perspective: Prospective
• Official Title: Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday: Data From a Single Outpatient Endocrine Clinic.
• Study Start Date: Sep 1, 2013
• Anticipated Primary Completion Date: Feb 1, 2014

Arms and Interventions

Arm	Intervention/Treatment
Postmenopausal women Postmenopausal women treated with bisphosphonates	Other: Questionnaires about compliance and persistence with bisphosphonates treatment

Outcome Measures

Primary Outcome Measures

1. Compliance and persistence to osteoporosis drug therapy [Participants will be followed for the duration of their clinic visit, an average of 5 hours]

   Data collection will be done by questionnaires and from the medical record of the patient. The information collected will include: demographic information, measurements of bone density, additional information about the disease and treatment that the patient receives,prescription purchases and additional drugs the patient is taking (steroids, PPI's(Proton Pump Inhibitors) / H2 receptor antagonists and NSAIDs(Non Steroidal Anti Inflammatories)).

Eligibility Criteria

Criteria

• Ages Eligible for Study: 40 Years to 90 Years
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Postmenopausal women

• Diagnosis of osteoporosis in the medical record

• At least one prescription drug to treat osteoporosis in the last 5 years

• Insured by "Clalit" Health Services

• Hebrew-speaking capability and readiness to answer a questionnaire

Exclusion Criteria:

• Premenopausal women

• No diagnosis of osteoporosis in the medical record

• No treatment for osteoporosis in the last 5 years

• Women who do not speak Hebrew or are unable to answer a questionnaire

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Meir medical center the clalit health care services group	Kfar Saba		Israel	44281

Sponsors and Collaborators

• Meir Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Meir Medical Center
• ClinicalTrials.gov Identifier: NCT01854086
• Other Study ID Numbers: MMC130009-13CTIL
• First Posted: May 15, 2013
• Last Update Posted: May 15, 2013
• Last Verified: May 1, 2013

• Keywords provided by Meir Medical Center: osteoporosis; postmenopausal; patient compliance; compliance; diphosphonates; bisphosphonates
• Additional relevant MeSH terms: Osteoporosis; Diphosphonates

Study Results

No Results Posted as of May 15, 2013